Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 4
2006 4
2007 2
2008 3
2009 3
2010 2
2011 2
2012 11
2013 14
2014 15
2015 19
2016 19
2017 8
2018 8
2019 19
2020 24
2021 27
2022 28
2023 24
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
3D culture models to study pathophysiology of steatotic liver disease.
Caddeo A, Maurotti S, Kovooru L, Romeo S. Caddeo A, et al. Among authors: romeo s. Atherosclerosis. 2024 Apr 15:117544. doi: 10.1016/j.atherosclerosis.2024.117544. Online ahead of print. Atherosclerosis. 2024. PMID: 38677899 Free article. Review.
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
De Vincentis A, Tavaglione F, Namba S, Kanai M, Okada Y, Kamatani Y, Maurotti S, Pedone C, Antonelli Incalzi R, Valenti L, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Among authors: romeo s. Aliment Pharmacol Ther. 2024 Jun;59(11):1402-1412. doi: 10.1111/apt.17953. Epub 2024 Mar 18. Aliment Pharmacol Ther. 2024. PMID: 38497224
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease.
Romeo S, Jamialahmadi O, De Vincentis A, Tavaglione F, Malvestiti F, Li-Gao R, Mancina R, Alvarez M, Gelev K, Maurotti S, Vespasiani-Gentilucci U, Rosendaal F, Kozlitina J, Pajukanta P, Pattou F, Valenti L. Romeo S, et al. Res Sq [Preprint]. 2024 Feb 6:rs.3.rs-3878807. doi: 10.21203/rs.3.rs-3878807/v1. Res Sq. 2024. PMID: 38405802 Free PMC article. Preprint.
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization.
Pennisi G, Maurotti S, Ciociola E, Jamialahmadi O, Bertolazzi G, Mirarchi A, Bergh PO, Scionti F, Mancina RM, Spagnuolo R, Tripodo C, Boren J, Petta S, Romeo S. Pennisi G, et al. Among authors: romeo s. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1086-1097. doi: 10.1161/ATVBAHA.123.319789. Epub 2024 Feb 22. Arterioscler Thromb Vasc Biol. 2024. PMID: 38385290 Free article.
Exploring the impact of the PNPLA3 I148M variant on primary human hepatic stellate cells using 3D extracellular matrix models.
Caon E, Martins M, Hodgetts H, Blanken L, Vilia MG, Levi A, Thanapirom K, Al-Akkad W, Abu-Hanna J, Baselli G, Hall AR, Luong TV, Taanman JW, Vacca M, Valenti L, Romeo S, Mazza G, Pinzani M, Rombouts K. Caon E, et al. Among authors: romeo s. J Hepatol. 2024 Feb 15:S0168-8278(24)00110-7. doi: 10.1016/j.jhep.2024.01.032. Online ahead of print. J Hepatol. 2024. PMID: 38365182 Free article.
Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, Passignani G, Norouziesfahani M, Sinopoli E, Baselli G, Meda C, Dongiovanni P, Dondossola D, Youngson N, Tourna A, Chokshi S, Bugianesi E; EPIDEMIC Study Investigators; Della Torre S, Prati D, Romeo S, Valenti L. Cherubini A, et al. Among authors: romeo s. Nat Med. 2024 Apr;30(4):1212. doi: 10.1038/s41591-024-02817-x. Nat Med. 2024. PMID: 38267549 Free PMC article. No abstract available.
224 results